Viewing Study NCT00626561

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:00 PM
Ignite Modification Date: 2026-01-26 @ 5:57 PM
Study NCT ID: NCT00626561
Status: TERMINATED
Last Update Posted: 2014-07-07
First Post: 2008-02-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
None Uterine Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cervical Cancer View
None Uterine Cancer View
None Bevacizumab View
None Avastin View
None Anti-VEGF monoclonal antibody View
None rhuMAb-VEGF View
None Paclitaxel View
None Taxol View